Add this topic to your myFT Digest for news straight to your inbox
Companies will seek to restore sight and cure liver condition by using technology like a drug
Only nine companies come to market while 21 shelve IPO plansa miserly
Cautious sentiment risks cutting off funding for smaller biotechs
International Edition